MMP9 and chronic obstructive pulmonary disease: In summary, the current clinical study suggests that LWBQ capsules could reduce inflammatory responses, improve pulmonary function of people suffering from stable COPD with lung-qi deficiency by up-regulating the expression of STAT6 and TIMP-1, down-regulating the expression of STAT4 and MMP-9.